Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography

Atopic dermatitis (AD) is an inflammatory skin disease associated with increased systemic and vascular inflammation. Although dupilumab has been proven to be effective against severe AD, imaging studies analysing its inflammation-reducing effect have rarely been reported. The aim of this study was t...

Full description

Bibliographic Details
Main Authors: Gi-Wook Lee, Keunyoung Kim, Seong-Jang Kim, Kihyuk Shin, Hoonsoo Kim, Hyun-Chang Ko, Moon-Bum Kim, Byungsoo Kim
Format: Article
Language:English
Published: Medical Journals Sweden 2023-05-01
Series:Acta Dermato-Venereologica
Subjects:
Online Access:https://medicaljournalssweden.se/actadv/article/view/5320
_version_ 1797822304904806400
author Gi-Wook Lee
Keunyoung Kim
Seong-Jang Kim
Kihyuk Shin
Hoonsoo Kim
Hyun-Chang Ko
Moon-Bum Kim
Byungsoo Kim
author_facet Gi-Wook Lee
Keunyoung Kim
Seong-Jang Kim
Kihyuk Shin
Hoonsoo Kim
Hyun-Chang Ko
Moon-Bum Kim
Byungsoo Kim
author_sort Gi-Wook Lee
collection DOAJ
description Atopic dermatitis (AD) is an inflammatory skin disease associated with increased systemic and vascular inflammation. Although dupilumab has been proven to be effective against severe AD, imaging studies analysing its inflammation-reducing effect have rarely been reported. The aim of this study was to evaluate the effect of dupilumab on systemic and vascular inflammation in adult patients with severe AD, using 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT). A total of 33 adult patients with severe AD and 25 healthy controls underwent 18F-FDG PET/CT at baseline. Patients on dupilumab treatment underwent 18F-FDG PET/CT again after achieving a 75% reduction from baseline on the Eczema Area and Severity Index (EASI-75). Patients with AD exhibited increased 18F-FDG uptake values in the liver, spleen, pancreas, and carotid artery compared with healthy controls. However, compared with baseline, there was no statistically significant difference in 18F-FDG uptake in major organs and arteries after achieving EASI-75 with dupilumab treatment. In conclusion, while dupilumab treatment resulted in a significant clinical improvement and reduced serum inflammatory markers in adult patients with severe AD, no changes in systemic and vascular inflammation were observed on 18F-FDG PET/CT imaging.
first_indexed 2024-03-13T10:06:02Z
format Article
id doaj.art-00251b98f2dc4c4580c2fa8bba228356
institution Directory Open Access Journal
issn 0001-5555
1651-2057
language English
last_indexed 2024-03-13T10:06:02Z
publishDate 2023-05-01
publisher Medical Journals Sweden
record_format Article
series Acta Dermato-Venereologica
spelling doaj.art-00251b98f2dc4c4580c2fa8bba2283562023-05-22T12:03:58ZengMedical Journals SwedenActa Dermato-Venereologica0001-55551651-20572023-05-0110310.2340/actadv.v103.5320Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed TomographyGi-Wook Lee0Keunyoung Kim1Seong-Jang Kim2Kihyuk Shin3Hoonsoo Kim4Hyun-Chang Ko5Moon-Bum Kim6Byungsoo Kim7Department of Dermatology, School of Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Nuclear Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Nuclear Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Dermatology, School of Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Dermatology, School of Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Dermatology, School of Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Dermatology, School of Medicine, Pusan National University Hospital, Busan, KoreaDepartment of Dermatology, School of Medicine, Pusan National University, Busan, KoreaAtopic dermatitis (AD) is an inflammatory skin disease associated with increased systemic and vascular inflammation. Although dupilumab has been proven to be effective against severe AD, imaging studies analysing its inflammation-reducing effect have rarely been reported. The aim of this study was to evaluate the effect of dupilumab on systemic and vascular inflammation in adult patients with severe AD, using 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT). A total of 33 adult patients with severe AD and 25 healthy controls underwent 18F-FDG PET/CT at baseline. Patients on dupilumab treatment underwent 18F-FDG PET/CT again after achieving a 75% reduction from baseline on the Eczema Area and Severity Index (EASI-75). Patients with AD exhibited increased 18F-FDG uptake values in the liver, spleen, pancreas, and carotid artery compared with healthy controls. However, compared with baseline, there was no statistically significant difference in 18F-FDG uptake in major organs and arteries after achieving EASI-75 with dupilumab treatment. In conclusion, while dupilumab treatment resulted in a significant clinical improvement and reduced serum inflammatory markers in adult patients with severe AD, no changes in systemic and vascular inflammation were observed on 18F-FDG PET/CT imaging. https://medicaljournalssweden.se/actadv/article/view/5320Atopic dermatitisCardiovascular diseaseComorbidityDupilumabInflammationPET/CT: positron emission tomography-computed tomography
spellingShingle Gi-Wook Lee
Keunyoung Kim
Seong-Jang Kim
Kihyuk Shin
Hoonsoo Kim
Hyun-Chang Ko
Moon-Bum Kim
Byungsoo Kim
Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
Acta Dermato-Venereologica
Atopic dermatitis
Cardiovascular disease
Comorbidity
Dupilumab
Inflammation
PET/CT: positron emission tomography-computed tomography
title Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
title_full Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
title_fullStr Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
title_full_unstemmed Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
title_short Therapeutic Effect of Dupilumab on Systemic and Vascular Inflammation in Adults with Severe Atopic Dermatitis: Feasibility Study Using 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography
title_sort therapeutic effect of dupilumab on systemic and vascular inflammation in adults with severe atopic dermatitis feasibility study using 18f fluorodeoxyglucose positron emission tomography computed tomography
topic Atopic dermatitis
Cardiovascular disease
Comorbidity
Dupilumab
Inflammation
PET/CT: positron emission tomography-computed tomography
url https://medicaljournalssweden.se/actadv/article/view/5320
work_keys_str_mv AT giwooklee therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT keunyoungkim therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT seongjangkim therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT kihyukshin therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT hoonsookim therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT hyunchangko therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT moonbumkim therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography
AT byungsookim therapeuticeffectofdupilumabonsystemicandvascularinflammationinadultswithsevereatopicdermatitisfeasibilitystudyusing18ffluorodeoxyglucosepositronemissiontomographycomputedtomography